S'pore drug development gets another shot in the arm
One goal for EDDC will be to create projects that are attractive to multinational pharmaceutical companies
Add BT as a preferred source
Singapore
A*STAR officially opened the new Experimental Drug Development Centre (EDDC) on Wednesday to take more made-in-Singapore drugs from early-stage drug discovery to clinical trials and commercialisation.
Towards this end, the statutory board also launched the Target Translation Consortium (TTC), which coordinates drug discovery efforts in academia, healthcare institutions and government agencies, and consolidated three existing A*Star grants into the Singapore Therapeutics Development Review (STDR).
TRENDING NOW
Simba ordered to pay S$700,000 in damages to indoor skydiving operator Altitude Xperience for trespass
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
Great Eastern goes on the high-net-worth offensive, but don’t call it a pivot
UK PM Starmer resigns; new leader to be in place by September
